Duato Joaquin sold $12.5M of JNJ
Duato Joaquin (CEO and Chairman of the Board) sold 48,480 shares of JOHNSON & JOHNSON (JNJ) at an average of $258.15 ($258.06–$258.74, $12.52M total) across 2 trades on 2026-08-05.
How this was made
The 30-second read
Why it matters
The newest fact is the quantified open-market sale by the CEO and Chairman, including trade dates, share count, and total value.
Market read
Traders may monitor insider activity for sentiment, but this filing alone does not change the company’s fundamentals.
What to watch
Form 4 does not reveal whether additional sales or purchases occurred around the same period, nor does it indicate whether the executive retained exposure via options or other vehicles.
Background
The article is an SEC Form 4 insider transaction disclosure for Johnson & Johnson.
Ticker impact
SEC Form 4 shows CEO and Chairman Duato Joaquin sold 48,480 shares of JNJ in open-market trades totaling about $12.5M on 2026-08-05.
Likely limited, short-lived sentiment impact; no direct signal on earnings or guidance from the filing alone.
The filing is a primary-source Form 4 and quantifies the sale size and timing, but it provides no new operational or financial information and notes no 10b5-1 plan.
Market effects
Insider selling at a mega-cap healthcare name can marginally influence sentiment across large-cap pharma/medtech, but no sector-specific catalyst is provided.
None indicated.
None indicated.
Counterpoint
The absence of a stated 10b5-1 plan does not necessarily imply negative fundamentals; sales can be driven by diversification, taxes, or pre-planned personal liquidity needs.
Key entities
- issuerJohnson & Johnson
Subject of the Form 4 insider sale disclosure.
- insiderDuato Joaquin
CEO and Chairman of the Board who sold shares in open-market transactions.
